Mark Bishton

Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor–induced thrombocytopenia

Mark Bishton, Simon J. Harrison, Benjamin P. Martin et al. · Blood · 2011 · 134 citations · Full text

Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma

Michael Dickinson, David Ritchie, Daniel J. DeAngelo et al. · British Journal of Haematology · 2009 · 87 citations · Full text

Combination chemotherapy followed by autologous stem cell transplant for enteropathy‐associated T cell lymphoma

Mark Bishton, Andrew Haynes · British Journal of Haematology · 2006 · 74 citations

Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity

Toby A. Eyre, Amy A. Kirkwood, Julia Wolf et al. · British Journal of Haematology · 2019 · 64 citations · Full text

Kinetics of T‐cell subset reconstitution following treatment with bendamustine and rituximab for low‐grade lymphoproliferative disease: a population‐based analysis

Nicolás Martínez‐Calle, Sarah Hartley, Matthew J. Ahearne et al. · British Journal of Haematology · 2018 · 56 citations · Full text